Viable Vaccine Candidate for COVID-19 Developed Using Proprietary Plant-based Technology |
|
Canadian biopharmaceutical company Medicago announced that it has successfully produced a Virus-Like Particle (VLP) of the coronavirus 20 days after obtaining the SARS-CoV-2 (the virus causing the COVID-19 disease) genetic sequence. Medicago produced the VLP using proprietary plant-based technology. The production of the VLP is the first step in developing a vaccine for COVID-19 which will now undergo preclinical testing for safety and efficacy.
|
|
|
|
Ugandan President Ready to Sign GMO Bill into Law |
|
Ugandan President Yoweri Museveni has given the clearest indication yet that he is ready to sign the National Biotechnology and Biosafety Bill into law. The President has directed the ruling National Resistance Movement (NRM) caucus to convene a meeting and resolve the impasse that has stalled the passing of the bill into law.
|
|
|
|
|
|
|
|
A biweekly update on gene editing research, regulations, and impact
produced by ISAAA Inc. |
|
|
|
|
A monthly update on gene drive research and development provided by ISAAA in collaboration with the Outreach Network for Gene Drive Research |
|
|
|
|
GM APPROVAL UPDATES |
- The Philippines approved the canola event LBFLFK for food, feed, and processing.
- The Philippines approved the cotton event GFM cry1A for commercial cultivation.
- Brazil approved the wheat event HB4 for commercial cultivation.
- The Philippines approved the soybean event GMB 151 for food, feed, and processing.
- The Philippines approved the eggplant event EE-1 for cultivation
- The USA approved the canola event MON94100 for food and feed.
|
|
|
|
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. |
|
|
|